There has been a surge of interest in understanding the regulation of metabolic networks involved in disease in recent years. Quantitative models are increasingly being used to interrogate the metabolic pathways that are contained within this complex disease biology. At the core of this effort is the mathematical modeling of central carbon metabolism involving glycolysis and the citric acid cycle (referred to as energy metabolism). Here, we discuss several approaches used to quantitatively model metabolic pathways relating to energy metabolism and discuss their formalisms, successes, and limitations.
INTRODUCTION
T he accumulated amount of biochemical work carried out over the years has elaborated complex metabolic systems and networks. This information includes the network architecture encoded in chemical reactions that are carried out by metabolic enzymes and the kinetic parameters that determine reaction mechanisms involved in each of these chemical reactions. Application of this knowledge has led to tremendous predictive capability in characterizing metabolic regulation in normal physiology including the growth of unicellular organisms and the successful simulation of energy metabolism in healthy red blood cells. However, there are far fewer instances in which these models have been applied to the characterization of pathophysiology. Applying our knowledge of metabolic regulation to the investigation of disease states such as cancer or neurodegeneration is currently a scientific frontier. In this review, we will revisit several classic techniques for the mathematical modeling of metabolic pathways and discuss instances where their application to biomedical science is beginning to yield fruitful dividends.
LINEAR SYSTEMS: FLUX BALANCE ANALYSIS
Linear models are mathematical models that contain a set of algebraic equations based on the stoichiometric relationships that define conservation relationships within a metabolic network. Linear models, to our knowledge, were first applied to biochemical systems in 1961 by Shapiro. 1 Shapiro discussed the possibility of using optimization in biochemical linear models in a 1969 publication. 2 In 1984, a model incorporating glycolysis and the tricarboxylic acid cycle (TCA) cycle was employed running a variant of Dantzig's algorithm with the assumed biological objective of minimized free energy dissipation. 3, 4 An enduring research program was initiated by Palsson half a decade later. 5, 6 An early work of Edwards and Palsson showed that growth maximization in an Escherichia coli model could correctly match 86% of 79 gene essentialities examined. 7 Subsequent modeling in Saccharomyces cerevisiae was able to closely predict growth rates and exometabolic fluxes in various media, and nearly capture the in vivo phosphate/oxygen (P/O) ratio of 0.94 with a simulated P/O value of 1.04, showing that models of eukaryotes were also feasible. 8 If one chooses the biological objective function to reflect the appropriate physiological demands, then it is possible to predict features of adaptation; this was shown to be the case for growth optimization in several E. coli mutants.
By this time it had become apparent that linear models held much promise, particularly when coupled with optimization.
Genome-Scale Modeling
Today, when we refer to linear models, we most often mean constraint-based models (CBMs). We refer to a CBM as any model making use of the stoichiometric matrix, S, as a linear matrix constraint, e.g., S * F = 0, where F is a flux vector. In fact, this is a nearly universal constraint, as it guarantees conservation of mass during steady-state processes such as exponential growth or tissue maintenance. 10 Other constraints commonly used include reversibility constraints when the direction of a reaction is known for physiological conditions of interest, bounds on the uptake of nutrients or efflux rates due to regulation or physiology, or bounds on enzyme reactions when the maximum enzyme velocity V max is known.
Because these constraints give rise to an underdetermined system, it will not be possible to identify a unique solution for the flux vector. A unique solution is often desirable as it allows investigators to analyze a putative metabolic phenotype. Indeed, this is one of the more convenient features of linear optimization: the ability to get meaningful solutions without explicitly taking into account any, or at least very few, free parameters. Flux balance analysis (FBA) assumes a linear combination of fluxes to be maximized or minimized (Figure 1 ). In microbes, perhaps the most popular FBA objective has been growth maximization, which consists of the biomass precursors and products formulated as a single pseudo-reaction. Additionally, an ATP maintenance constraint should be formulated as a sink reaction with the molar ATP required to keep 1 g of dry weight biomass living for 1 h. 11 This empirically determined constraint, although assumed, is less discussed, perhaps owing to its dependence on individual strains and environments. We note that for many expression-based methods in the CBM framework, the ATP maintenance constraint is not required (see Table 1 and Figure 2 for examples). Fixed biomass objectives by themselves also have some undesirable qualities; biomass composition likely has some measure of variability based on genetic background and environment. Robust FBA attempts to address this problem by allowing some variation in the biomass composition, as determined by variation of empirical assays of biomass. 12 Despite these caveats, FBA has recently been found to not only predict growth in microbes but also has good agreement with gold standard 13 C flux assays in vivo when the growth objective is used along with ATP synthesis maximization and minimization of absolute fluxes. 13 Minimization of absolute flux is a commonly used objective employed alongside other objectives, forming a minimax problem (i.e., finding the minimum absolute flux profile among all flux profiles that maximize biomass). This approximates the biological goal of being efficient with enzyme production costs and enzyme crowding constraints while also guaranteeing that no thermodynamically impossible loops are present, that is, ruling out some fluxes that might otherwise violate Kirchoff's loop rule. 14, 15 This constraint will work whenever a sink reaction, such as growth, is being optimized. However, maximizing an internal flux, as in flux variability analysis, 16 could still result in internal cycles. 15 Initial thermodynamic approaches involved nonlinear optimization. [17] [18] [19] [20] Constraints satisfying Kirchoff's loop rule were later developed that were faster and more generally applicable than prior methods. 15, 21 Still, these involve integer constraints that put this problem in a slower class of algorithms than the convex minimized absolute flux problem. When available, thermodynamic data is valuable; it can not only be used to guarantee that there are no internal cycles but can also aid in determining reaction direction and potential regulatory targets. 15, 18, 22, 23 Application of this framework to concentration data allows unmeasured metabolite concentrations to be inferred and global concentrations to be resolved at the organelle level. 20 CBMs have also found use in tracing individual atoms through pathways, which provide a more appealing framework for performing metabolic flux analysis (MFA; discussed below) on stable isotope data owing to the lack of bias compared with typical MFA models, which are often an order of magnitude smaller than genome-scale reconstructions. 24 Recent insightful work has made it possible to simplify the computational complexity of loopless FBA to be nearly the same as conventional FBA, but some mathematical difficulties must still be overcome before bounds on exchange fluxes can be suitably incorporated for genome-scale modeling.
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The metabolism of different tissues within the same organism is diverse; whereas the metabolism in liver is anabolic, neurons or red blood cells have a much more limited catabolic regime. [26] [27] [28] The creation of tissue-specific models for multicellular organisms has become an important problem, and several automated algorithms taking as inputs tissue expression data and a generic model for the organism have been developed. [28] [29] [30] Coupling multiple cellular models together will enable multiscale modeling of 
FIGURE 2
| Schematic representation of fluxomics tools. Important to fluxomics are both the mathematical and computational tools for nonlabeled and labeled techniques, as well as the analytical methods used to obtain data and parameters. Metabolite concentrations and kinetic parameters are obtained primarily from both gas chromatography-and liquid chromatography-mass spectrometry (GC-MS and LC-MS), nuclear magnetic resonance (NMR), UV-vis spectroscopy, electrochemistry, Förster (fluorescence) resonance energy transfer (FRET), positron emission tomography (PET), liquid scintillation counting (LSC), and classical enzymology. Sequence data is employed in the construction of organism models, whereas proteomics and expression data find use in the creation of tissue-or cell-type-specific models. High-quality expression data such as RNA-seq and ribosomal footprinting are beginning to find uses in flux prediction. Several prominent genome-scale techniques include flux balance analysis (FBA), minimization of metabolic adjustment (MoMA), energy balance analysis (EBA), ExPas (extreme pathways), and elementary mode analysis (EMA). Isotope-based approaches include stable isotope techniques (mostly convenient 13 C MFA and other nuclei, namely 17 O, 31 P, 2 H, and 15 N used to study central metabolism), hyperpolarized 13 C [dynamic nuclear polarization (DNP)], and radioisotopes that are studied with PET and LSC. Well-established MFA tools include isotopomer and positional modeling, which could be studied dynamically or at steady state (SS). With hyperpolarized technique it is possible to extract energy-related fluxes like pyruvate dehydrogenase flux Fpdh, lactate production rate Flac, and tricarboxylic acid flux Ftca (e.g., with [1-or 2-13 C]Pyr as tracers). With other nuclei, the metabolic rate of oxygen consumption MRO 2 and ATP production MRATP and amino acid (AA) fluxes could be accessed directly. Advanced isotopomer techniques include cumomer approach with elementary metabolite units (EMU) and bonded cumomer frameworks designed to reduce the number of independent variables while retaining all measurable isotopomer information. Nonlabeled techniques along with genome-scale analysis include biochemical kinetics modeling tools to study metabolic and signaling networks and their regulation architecture with established tools like metabolic control analysis (MCA) and global sensitivity analysis (GSA). Additional sensitivity analysis should be conducted, e.g., with Monte-Carlo techniques like Markov chain Monte-Carlo (MCMC, Bayesian) analysis to check the reliability of extracted metabolic parameters, including fluxes.
tissues in multicellular models or entire ecosystems for microbes. 26, [31] [32] [33] Automated generation of metabolic networks from genome sequence and pathway databases, especially in prokaryotes, has been developed. [34] [35] [36] [37] This will offer many advantages to modelers: a starting point for curated models (a draft reconstruction is estimated to often take several months even in prokaryotes), a means for doing population or ecological simulations, 33 and personalized genomic modeling for patients with metabolic syndromes such as cancer where both the patient and possibly the disease have diverse genotypes. 38, 39 Eukaryotic models are somewhat more difficult to generate owing to the necessity of protein localization and metabolite transporter information. 34 Automatic reconstruction going beyond enzymatic gene information, such as regulatory FBA (rFBA) models, should also be possible; 40, 41 the automated generation of Boolean and higher order discrete regulatory models using time-series expression data has been explored as well, although to date these regulatory models have not been coupled to metabolic reconstructions. [42] [43] [44] [45] These approaches and other families of genome-scale methods are discussed in Table 1 .
Several approaches have been used in applying CBMs to cancer and the Warburg effect, the preference for glycolytic ATP production over glucose-derived mitochondrial ATP production in cancer cells. [54] [55] [56] An important study working with a simplified model of central carbon metabolism showed that, while the TCA cycle predicts better ATP yield than glycolysis when only available glucose is considered as a constraint, the addition of enzyme solventcapacity constraints creates a preference for ATP synthesis through glycolysis. 56 More recently, the work of Vazquez and Oltvai was extended to include a genome-scale model along with enzyme solvent-capacity constraints, which was able to show significant correlations between fluxes and expression in the NCI-60 cell line panel, as well as predicting an intermediate state in cancer metabolism transition exhibiting a temporary increase in OxPhos that was supported by two prior experimental observations. 55 Each of these approaches correctly predicted lactate production. Concurrent research on predicting cancer targets was carried out by screening for simulated negative epistasis in cancer tissue-specific models that have at least one known-drug target and no known effect on normal tissue revealed many epistatic interactions. 39 A related study confirmed one of these synthetic lethalities between heme oxygenase and fumarate hydratase, a mutation found in certain kidney cancers. 57 The recent publication of Human Recon 2 promises to aid in the understanding of many human diseases; already 65 cell-type-specific models based on it are available, and the model reports 77% accuracy in identifying metabolic markers across 49 inborn errors of metabolism. 58 Although this model is a great step forward in consolidating much of the knowledge about human metabolism, it is only one of many steps to come. For instance, this model is still primarily only amenable to steady-state approaches, lacks corresponding enzyme-regulatory and signaling architecture, and has introduced more dead-end metabolites than it removed (1176 vs 339).
Conclusions
Kinetic models for smaller pathways are possible when the data are present, but many energetic questions concern the entire cell, leaving only incorporation of CBMs as a viable option. The original efficiency and ease of use of FBA have helped propagate a field of more diverse algorithms that are often tractable on today's computers using the same modeling and software frameworks. 59, 60 Numerous methods and successful applications in energy metabolism exist, including prevalent diseases such as heart disease, cancer, and Alzheimer's. 61 Multiscale models, as were used in the Alzheimer's models, will undoubtedly become more common. At the intracellular scale, CBMs are also beginning to incorporate information other than metabolic stoichiometry. [62] [63] [64] A whole-cell model for Mycoplasma genitalium incorporating information about all classes of macromolecular synthesis and degradation, in addition to stoichiometric and regulatory information, found a nonstochastic coupling between metabolism and the cell cycle where DNA replication rates depended on the concentration of dNTP. 63 Models like these are not easy to build, but substantial endeavors are underway to assist in their draft construction and refinement, and together with an increase in use of jamboree meetings of organism and model experts and online collaborative tools, and will likely aid in creating public models of higher quality and the understanding of many biological processes outside the traditional scope of metabolism. 35, 58, [65] [66] [67] [68] [69] 
BIOCHEMICAL KINETIC MODELING
Biochemical kinetic models describe dynamic properties of metabolic and signaling networks, predicting a variety of different properties, e.g., fluxes, metabolite concentrations or complex dynamic behavior with multiple steady states, oscillations, and bifurcations 70 ( Figure 2) . These kinetic models form mechanistic descriptions of metabolic networks and are able not only to predict effects of environmental stresses or genomic changes but also allow for the investigation of network robustness and design principles. To generate such a model, kinetic parameters must be included in the model explicitly. In practice, this requirement makes such models substantially underdetermined. As a result, extensive parameter sensitivity evaluations are required for all model calculations. In this section, we discuss the basic formalism of kinetic models. Because of space limitations we do not consider here some important strategies such as parameter estimation, model validation, and other types of analysis of network models and instead we refer to approaches reviewed recently.
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Kinetic Models of Metabolic Networks
To construct kinetic models, several types of data are required. A component of all metabolic networks is stoichiometry and this was discussed above (stoichiometric matrix S: see also FBA part, Eq. (1)).
where S is the stoichiometry matrix, M and F are the concentration and flux vectors, and p is the parameter vector. Presently, metabolic pathway charts are known for many organisms and tissues and there are several databases containing this information, e.g., KEGG metabolic pathways database (see Box 1). Construction of models requires the use of mechanistic enzyme flux equations and their reaction laws. The reaction rate (F, Eq. (1)) depends on the concentration of metabolites and kinetic/thermodynamic parameters: V max , the maximum activity of the enzyme, turnover rates, Michaelis-Menten constants, effector constants, and others. There is a lot of literature available for enzyme kinetics. 73, 74 A limiting factor in construction of complex dynamic models is the lack of knowledge of kinetic mechanisms and the difficulty in experimental identification of parameters. So, the common strategy in computational biology is to reduce the number of unknown parameters and consequently to use simplified or generic rate equations. 75, 76 Another alternative modeling approach, hybrid dynamic modeling, combines detailed mechanistic kinetics for regulatory enzymes with simplified rate equations with a small number of parameters for the remaining reactions. 77, 78 To check the reliability of this approach, Bulik et al. 78 have applied it to two independent metabolic networks including one involving energy and redox metabolism of red blood cells. Calculations of stationary and temporary states under various physiological challenges demonstrate the good performance of the hybrid models.
Constructions of dynamic models with multilevel hierarchical networks that include the integration of multiple biological processes including metabolism, signal transduction, genetic regulation, 87 and even living whole cell 63 Modeling of metabolic dynamics from the cellular to organ level is a powerful tool for interpreting experimental data. Recently, several kinetic models at the organ level were developed to study energy metabolism in brain, [88] [89] [90] muscle, 75, 76 and heart. 91, 92 These modeling approaches allow for the evaluation of the relative significance of metabolic pathways and regulatory mechanisms, and the prediction of responses to environmental stimuli that cannot be directly measured such as the introduction of a drug. These models are also being applied to bioenergetics of diseases such as Parkinson's desease. 93 
Sensitivity Analysis and Metabolic Control
Mechanism-based models predict dynamics in a specified system for each set of determined system parameters. However, it is important to further investigate the effect of parameter perturbations on the overall system. Identification of network control points, robustness, and parameter sensitivities is most crucial to the prediction of the system output behavior. Local parameter sensitivity analysis has been used to identify critical parameters in dynamic models of, e.g., muscle energetics 76 and excitable cell ATP dynamics. 94 The local sensitivity coefficient is defined as:
where p represents the parameter that is varied, R is a response of the system output such as a concentration or flux, and subscript ss means differentiation at steady state. Local sensitivity analysis allows only one parameter to vary for each calculation, deals with small perturbations, and is most widely used in metabolic systems. 70 However, parameters can vary extensively, and for this reason it is more appropriate to explore the possibility of nonlinear effects from simultaneous variations of arbitrary magnitude by means of global parameter sensitivity analysis (GSA). 71, 95 GSA has the advantage that it allows for a more comprehensive analysis by applying a MonteCarlo strategy to sample distributions of random parameters. 95 For each parameter set the sensitivity indices are calculated by minimization of an objective function, defined as a sum of squared errors between perturbed and reference or experimental output. 95 Metabolic control analysis (MCA) is a form of sensitivity analysis that is used in metabolic engineering. MCA computes the extent to which an enzyme controls a flux or concentration in the network. Control coefficients describe the relative sensitivities of dependent variables to independent system parameters. MCA helps to elucidate the distribution of concentration and flux control coefficients (FCCs). This approach was developed independently by two groups in the seventies. 96, 97 In particular, control coefficients describe the change in system variables as a result of perturbation of particular enzyme concentrations (independent parameter). The magnitude of change in pathway flux in response to enzyme concentration change is expressed as the FCC 97 
C F
where C
is the FCC of the ith enzyme, F is the steady-state flux, E i is the activity of ith enzyme, and the subscript ss means differentiation at the new steady-state condition. One feature of MCA is that control properties result from log-log derivatives. As a result, summation theorems state that, e.g., for FCC the sum of all FCCs in the metabolic network is equal to 1. 97 Although sensitivity analysis is widely used in kinetic modeling, it is rarely used in genome-scale modeling techniques such as FBA. This is despite the fact that early publications discuss the notion of shadow prices, which describe the rate of change in the objective function with respect to a particular flux, as well as prominent toolboxes featuring implementations of MCMC sampling strategies.
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Conclusions
In summary, mechanism-based kinetic models, though applied to limited bionetworks, provide a thorough understanding of biological systems. To understand Volume 5, November/December 2013dynamic features of metabolic networks, parameter fits are not necessary, especially when experimental data is limited or not available. In these regards, sensitivity analysis becomes a significant tool to study dynamic flux control and has the potential to develop models that possess prognostic power.
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STABLE ISOTOPE TRACING AND MFA
MFA employs stable isotope tracing and aims to characterize fluxes based on the distribution of labeling patterns of heavy isotopes (most commonly 13 C) that are introduced into cells. MFA can yield novel insight into the operation of biological systems, e.g., discovering features such as network mechanisms, novel pathways, futile cycles (substrate cycling), or alternative reactions. A large set of fluxes in a flux map is described as a fluxome and was defined by Sauer et al. 99 as the array of fluxes for all the reactions in a living system. The field of fluxomics aims to analyze this set of fluxes 99 (see Figure 2) . In metabolome-wide MFA the number of measurements from labeling experiments is usually much larger than the number of fluxes to be determined. This makes flux estimation an overdetermined problem in mathematical terms. The challenges of modern MFA have provided the motivation to develop additional theoretical frameworks to study the fluxome. For example, the details of flux analysis based on cumomers (see Boxes 2 and 3) are explained in series of articles. [100] [101] [102] Alternative methods such as elementary metabolite units 103 and bonded cumomers 104 aim to minimize the number of necessary state variables and to reduce computational cost.
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BOX 2 GLOSSARY FOR MFA
Isotopomer (or sometimes refer as isotopologue): 'Isotopic' molecule that represents one possible labeled state of a given substrate and so differing in position of isotopes. For metabolite M with n different carbon atoms there are 2 n possible isotopomers (if labeled with two isotopes, e.g., 12 C or 13 C isotopes). Particular isotopomer M(i1, i2 . . . in) is the isotopomer with labeled atoms in i1, i2 positions. For example, the Glu(1,2) isotopomer of glutamate is labeled with its first and second carbon atoms and all other atoms are unlabeled.
Mass isotopomer: A set of isotopomers with the same mass. For instance, the massisotopomer alanine M + 2 (AlaM2) contains all isotopomers with two labeled atoms. A molecule with n carbon atoms has n + 1 mass isotopomers.
Cumomer: The set of isotopomers of metabolite M that contain a particular labeled fragment, 100 thus representing a 'virtual' isotopic molecule. Cumomer M[i1, i2 . . . ik] is the set of isotopomers with labeled i1, i2 . . . ik atoms. For example, Lac [1, 2] cumomer of lactate with labeled first and second atoms and the third atom is either labeled or unlabeled. Total number of cumomers for molecule with n different carbon atoms equals to total number of isotopomers, 2 n .
Bonded cumomer: Cumomer whose indices refer to adjacent carbons. 104 Lac [1, 2] -bonded cumomer and Lac [1, 3] nonbonded.
Flux (F): Rate of reaction, expressed, e.g., in mkmol/g/min. Reflect in vivo enzymes activity and pathways rate. Flux information is important for mechanistic metabolic and disease pathophysiology studies.
Net flux: Difference between reaction forward and backward fluxes F f − F b .
Exchange flux (F e ): Often referred as a minimal flux between forward or backward fluxes, usually when
Fluxome: Set of fluxes for the reactions in organism network. The term was introduced by Sauer et al. in 1999. 99 Fluxomics: The discipline that applies different computational methods to analyze fluxome.
FBA family: Steady-state analysis of fluxes, based, e.g., on measured input and output (transport) fluxes or whole gene, protein expression, and linear programming.
MFA: Steady-state or dynamic analysis of fluxes based on the network stoichiometry and on the redistribution of labeled patterns of metabolites.
These fluxomics methods are classified as dynamic or static (steady state) depending on the manner of measurement of labeled metabolite patterns. Isotope-based MFA has been applied successfully to complex bionetworks with metabolic cycles, subcellular compartmentalization, reaction reversibility, and futile substrate cycling. Recently, MFA has become a widely used tool. The general methodology for both isotopically steady state and dynamic approaches for 13 C MFA and 13 C metabolic modeling has been reviewed recently, with applications to mammalian physiological systems (e.g., brain), 114, [116] [117] [118] [119] MFA currently represents one of the most powerful fluxomics techniques to estimate network fluxes, allowing estimation of both net and exchange fluxes within multicellular and subcellular compartments (Figure 2 ). MFA differs from FBA by incorporating the data from experiments using isotope-labeled nutrients (i.e., a tracer) into a metabolic model, and in general is a nonlinear problem. Tracers are supplied continuously to a biological system at metabolic steady state and labeling patterns of downstream metabolites are analyzed. However, it is possible to feed tissue or cells with a limited quantity of label, e.g., with a bolus or pulse, and this infusion technique is relatively common in physiological in vivo temporal studies. 114 The propagation of labels through a network depends on the network's structure, activity of network enzymes (fluxes), and pool sizes; larger pools slow down propagation and higher fluxes accelerate it. 116 Isotopic enrichments or patterns in metabolites are usually measured by mass spectrometry (MS) coupled with liquid chromatography (LC), gas chromatography (GC) and NMR. The isotopes most often used to study bioenergetics are 31 P (e.g., brain ATP rate analyzed by NMR), 124,125 17 O (e.g., cerebral oxygen metabolism by NMR), 125,126 18 O (whole-body energy balance by MS), 127 2 H (e.g., lactate recycling by NMR), 128 and most commonly 13 C (see above, NMR and MS). The ability to use NMR spectroscopy to study energy metabolism was demonstrated for 31 P 129 and for 13 C 130,131 using suspension cultures of microorganisms. Thereafter, seminal in vivo kinetics studies of energy metabolism have been made with 13 C in perfused heart 132,133 and liver, [134] [135] [136] and noninvasively in brain 137, 138 and skeletal muscle 139, 140 using different models. Technological advances in NMR and MS have led to advances in metabolomics. 141 In parallel, analytical techniques for 13 C MFA have been developed-from relatively simple to complex multicompartmental models with extended bionetworks represented by large numbers of equations. These models were able to demonstrate that human brain energy metabolism has not only a neuronal but also glial component, and have further shown that in glia, TCA cycle and anaplerotic pyruvate carboxylase activity are significant, 142 and that neuronal TCA cycle activity increases during visual stimulation 143 and decreases during normal aging, leading to a neuronal loss of oxidative capacity. 144 Both NMR and MS are capable of measuring label distribution in glycolysis and TCA cycleassociated intermediates. High-resolution LC-MS methods allow for the assessment of all mass isotopomers (n + 1 in total for a metabolite with n carbon atoms, Box 2) of glycolytic and TCA cycle Volume 5, November/December 2013intermediates, many of which are not detectable by NMR owing to low sensitivity. However, NMR gives more specific information about metabolites' positional enrichments via its analysis of 13 C multiplet spectra (e.g., Glu4-glutamate labeled at C4 position and other amino acids associated with TCA cycle glutamine and aspartate). Still, even this technique is not able to quantify all possible molecules that differ only in their isotope distribution (i.e., isotopomers, see Box 2) (=2 n for a molecule with n different carbon atoms) with one exception. 145 Therefore, the combination of both methods could potentially give more valuable metabolic information about bionetworks and better precision for calculated fluxes.
High sensitivity could favor the use of radioisotopes [analyzed by liquid scintillation counting and/or positron emission tomography (PET)] and 13 C hyperpolarized compounds for flux studies. They are particularly convenient if there is no need for positional labeling information. An interesting use of 11 C isotope with PET and a mathematical model to study neuroenergetics was recently published. 146 Detailed mathematical models are required for the correct interpretation of experimental data and to analyze isotopic patterns to calculate in vivo fluxes. Metabolic models differ depending on isotopic specificity of the input data, but three families can be distinguished: positional models, mass-isotopomer models, and isotopomer models (see Figure 2) . Most metabolic labeled experiments are limited to measurement of positional fractional enrichments of metabolites (in the case of 13 C NMR, the yield is at most n independent variables for a metabolite with n asymmetrical carbon atoms) and to only one or few mass isotopomers from all MS data (n + 1 mass isotopomers). As a consequence, there has been no complete description of isotopomer distribution dynamics, resulting in the loss of a lot of mechanistic biochemical information and the reliable determination of metabolic parameters. The main targets of modern isotopomer modeling approaches relate to the accurate determination of metabolic fluxes, improving their reliability and providing maximal metabolic information that can be derived from the fine structure of 13 C NMR spectroscopy of metabolites and/or metabolome-scale 13 C mass-isotopomer distributions (Box 3)
CONCLUSIONS
Various approaches for MFA have been employed recently, with the most advanced being cumomer modeling. Despite these advances in the theoretical basis for MFA, it is still an expanding and very active research field. Further progress will combine different analytical and experimental techniques, e.g., MS and NMR data with advanced dynamic and steady-state MFA techniques capable of handling heterogeneous data.
There is a significant value for MFA in many biomedical fields. High-performance 'omics' tools expand the application of flux analysis further to understand in vivo metabolism and its mechanisms and regulation under different conditions, elucidating the pathological mechanism of diseases, providing information on bottleneck reactions, and identifying specific steps for drug targets. Moreover, by providing information on flux in individual cells and tissues, MFA can significantly expand the potential of 'omics' techniques.
SUMMARY
Fluxes through metabolism directly report in vivo enzyme reaction rates. To comprehensively understand metabolism and elucidate its regulation all three flux modeling approaches should be applied. Each of these modeling approaches (linear modeling, kinetic modeling, and MFA) has successes and limitations. There have been a variety of successes in modeling energy metabolism with steady-state techniques, from the better understanding of diseases as diverse as Alzheimer's disease and host-pathogen diseases to predicting treatments for cancer. Despite such amazing successes, it must be cautioned that these models are far from perfect; 77% of metabolic biomarkers for inborn errors in metabolism can be predicted with correct directionality with the recently published Human Recon 2, and while a great achievement, still leaves much room for improvement. The yeast models, which have also shown much promise in predicting many phenotypes, have difficulty when predicting effects requiring greater precision, such as epistasis. Undoubtedly, this is largely due to the incompleteness of the reconstructions themselves. For several of the more popular model organisms, iterative improvements of reconstruction releases remain an active area of research. Other model organisms, such as Drosophila melanogaster, a model organism often used for studying mitochondrial defects, do not yet possess even a draft reconstruction. The parallel advances in modeling techniques enable the reconstructions to serve a dually important role as mathematically and experimentally verified databases; errors can easily be found by computational procedures, showing us where more experiments are needed to fill the gaps.
A limitation of linear models themselves is their inability to simulate dynamics. But, this is a somewhat artificial constraint, as integrated techniques utilizing the same reconstructions have proven to be successful. Increasingly, integrated techniques and diverse types of data underlying organism or cellular modeling will also play a vital role in improving predictive capability and a systematic knowledge base for biology. When trying to study individual or small sets of pathways, kinetic models may be relatively easy to implement if data is available, and data is rapidly becoming easier to generate with advances in mass spectrometry.
However, for many investigators, these methods may be neither easy to implement nor affordable to generate. Genome-scale models can cover more genes, with typically faster simulation times, making them particularly attractive to course-drained drug prediction or genetic interaction studies. In both cases, accuracy largely depends on the assumptions made by the user. Just because genome-scale methods such as FBA can be accurate and easy to run, does not mean a naive attempt will provide valuable predictions.
